Incidence of Candidaemia Following Abdominal Surgery in German Hospitals;Inzidenz der Candidämie nach gastrointestinal-chirurgischen Eingriffen in deutschen Akutkrankenhäusern

Zentralblatt fur Chirurgie - Zeitschrift fur Allgemeine, Viszeral- und Gefasschirurgie

Volumn 140, Issue 6, 2013, Pages 617-623

  Kuhns, M ^a   Rosenberger, A ^a   Bader, O ^a   Reichard, U ^a   Gross, U ^a   Weig, M ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

abdominal surgery; benchmarking; candidemia; incidence

Indexed keywords

ABDOMINAL SURGERY; BENCHMARKING; CANDIDEMIA; CROSS INFECTION; GERMANY; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SURGICAL WOUND INFECTION;

BENCHMARKING; CANDIDEMIA; CROSS INFECTION; DIGESTIVE SYSTEM SURGICAL PROCEDURES; GERMANY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; RISK FACTORS; SURGICAL WOUND INFECTION;

EID: 85017296076     PISSN: 0044409X     EISSN: 14389592     Source Type: Journal    
DOI: 10.1055/s-0033-1350814     Document Type: Article

References (12)

1. Borg-von Zepelin M., Kunz L., Rüchel R. et al. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005. J Antimicrob Chemother: 2007; 60 424 428
2. Kresken M., Groll A. H., Lass-Flörl C. et al. Bericht über die Ergebnisse einer multizentrischen Studie der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2010. In: Resistenzstudie 2010 - Abschlussbericht 2010 - Teilprojekt C Antiinfectives Intelligence. Rheinbach Paul-Ehrlich-Gesellschaft für Chemotherapie: 2013; 1 48 (http://www.p-e-g.org)
3. Gudlaugsson O., Gillespie S., Lee K. et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis: 2003; 37 1172 1177
4. Petri M. G., König J., Moecke H. P. et al. Epidemiology of invasive mycosis in ICU patients: a prospective multicenter study in 435 non-neutropenic patients. Paul-Ehrlich Society for Chemotherapy, Divisions of Mycology and Pneumonia Research. Intensive Care Med: 1997; 23 317 325
5. Arendrup M. C., Fuursted K., Gahrn-Hansen B. et al. Semi-national surveillance of fungaemia in Denmark 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect: 2008; 14 487 494
6. Pittet D., Monod M., Suter P. M. et al. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg: 1994; 220 751 758
7. Montravers P., Dupont H., Gauzit R. et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med: 2006; 34 646 652
8. Montravers P., Mira J. P., Gangneux J. P. et al. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect: 2011; 17 1061 1067
9. Cuenca-Estrella M., Verweij P. E., Arendrup M. C. et al. ESCMID∗ guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect: 2012; 18 07 S9 S18
10. Eloy O., Blanc V., Pina P. et al. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004]. Pathol Biol (Paris): 2006; 54 523 530
11. Holzknecht B. J., Thorup J., Arendrup M. C. et al. Decreasing candidaemia rate in abdominal surgery patients after introduction of fluconazole prophylaxis. Clin Microbiol Infect: 2011; 17 1372 1380
12. Hansen S., Schwab F., Behnke M. et al. National influences on catheter-associated bloodstream infection rates: practices among national surveillance networks participating in the European HELICS project. J Hosp Infect: 2009; 71 66 73